Although we were unable to distinguish between these two T-cell subpopulations, our approach to assessing the contribution of CD8+ T-cells was to examine their relative ratio to the suppressive Foxp3+ T-cells, which has been shown to be an effective surrogate for a physiologic threshold of anti-tumor activity [27]. This evidence concerns the gene CD8A and neoplasm.